We’re experiencing issues for some mobile devices with our ARTG dataset filter function. We apologise for any inconvenience while we work to fix this.
HYALASE hyaluronidase 1500IU powder for injection ampoule, Sanofi-Aventis Australia Pty Ltd , CON-785
Product name
HYALASE hyaluronidase 1500IU powder for injection ampoule
Sponsor name
Sanofi-Aventis Australia Pty Ltd
Batches
PVR10170, PWR10001 and PWR10002
Consent start
Consent no.
CON-785
Duration
The consent is effective from 14 May 2021 until 31 December 2021.
Standard
The European Pharmacopeia test for Loss on Drying (LOD) specification
Non-compliance with standard
The European Pharmacopeia test for Loss on Drying (LOD) specification, which is
LOD ≤ 5.0%.
Conditions imposed
This exemption only applies to drug substance batches PVR10170, PWR10001 and
PWR10002, as specified in the request.
Import, Supply, &/or Export
Import and supply
Therapeutic product type
Prescription medicines